Novel Coronavirus (SARS-CoV-2/COVID-19)
To support evidence-based nursing practice, the authors of a study in the February Nursing Outlook, used text mining to search the available literature on COVID-19 and other historical epidemics for information specific to nursing.
Writing in the February Nursing Management, AONL member Caryl Goodyear, PhD, RN, gave nurse leaders clear strategies for coping with the stressors “rearing their ugly heads during the pandemic.”
As part of its effort to provide recommendations on vaccine administration, the National Council of State Boards of Nursing (NCSBN) has joined the COVID-19 Vaccine Education and Equity Project.
The personal protective equipment clinicians require to limit their exposure to highly contagious pathogens creates communication challenges.
The latest Sentinel Event Alert from the Joint Commission summarizes more than 2,000 comments from health care workers,
The ECRI Institute’s annual Top 10 list of health technology hazards leads off with the complexity of managing medical devices that received emergency use authorization (EUA) during the COVID-19 pandemic.
Last week, the Department of Health and Human Services (HHS) expanded the categories of clinicians authorized to prescribe, dispense and administer COVID-19 vaccines.
Johnson & Johnson Innovation – JLABS, together with AONL and the Society of Nurse Scientists, Innovators, Entrepreneurs, & Leaders (SONSIEL), announced this week that IsoPouch and Pain Rehabilitation Virtual Reality (PR-VR) have been selected as the awardees in the Johnson & Johnson…
To help rural communities address the challenges of delivering quality care via telehealth, especially during emergencies, the National Quality Forum (NQF) announced it convened a committee this week in partnership with the Centers for Medicare & Medicaid Services.
Data released this week by Eli Lilly showed treatment with a combination of the company’s COVID-19 neutralizing antibodies bamlanivimab and etesevimab reduced the risk of COVID-19 hospitalizations and deaths by 70% among a group of more than 1,000 high-risk patients enrolled in a Phase 3 clinical…